English  |  正體中文  |  简体中文  |  Items with full text/Total items : 18054/20253 (89%)
Visitors : 24216520      Online Users : 59
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: https://ir.cnu.edu.tw/handle/310902800/34618

    標題: Efficacy of high flow nasal oxygenation against hypoxemia in sedated patients receiving gastrointestinal endoscopic procedures: A systematic review and meta-analysis
    作者: Hung, Kuo-Chuan
    Chang, Ying-Jen
    Chen, I-Wen
    Soong, Tien-Chou
    Ho, Chun-Ning
    Hsing, Chung-Hsi
    Chu, Chin-Chen
    Chen, Jen-Yin
    Sun, Cheuk-Kwan
    貢獻者: Chi Mei Hospital
    Department of Hospital and Health Care Administration, Chia Nan University of Pharmacy & Science
    Department of Recreation and Health-Care Management, Chia Nan University of Pharmacy & Science
    E-Da Hospital
    E-Da Hospital
    I Shou University
    Chi Mei Hospital
    E-Da Hospital
    關鍵字: randomized controlled-trial
    propofol-mediated sedation
    cannula oxygen
    moderate sedation
    upper airway
    日期: 2022
    上傳時間: 2023-12-11 14:00:59 (UTC+8)
    摘要: Study objective: To evaluate the impact of high flow nasal oxygenation (HFNO) on the risk of hypoxemia during gastrointestinal endoscopic procedures (GEPs) under sedation. Design: Meta-analysis of randomized controlled trials. Setting: Gastrointestinal endoscopy. Intervention: HFNO. Patients: Adults patients undergoing GEPs under sedation. Measurements: The primary outcome was risk of hypoxemia, while the secondary outcomes included risks of severe hypoxemia, hypercapnia, need for jaw thrust or other airway interventions, and procedural interruption as well as procedure time, minimum SpO(2), and level of carbon dioxide (CO2). Analyses based on age, gender, flow rate, risk status of patients were performed to investigate subgroup effects. Results: Medline, Google scholar, Cochrane Library, and EMBASE databases were searched from inception to July 2021. Seven randomized controlled trials (RCTs) involving 2998 patients published from 2019 to 2021 were included. All GEPs were performed under propofol sedation. Pooled results revealed significantly lower risks of hypoxemia [relative risk (RR) = 0.31, 95% CI:0.13-0.75; 2998 patients], severe hypoxemia (RR = 0.38, 95% CI:0.2-0.74; 2766 patients), other airway interventions (RR = 0.34, 95% CI:0.22-0.52; 2736 patients), procedural interruption (RR = 0.12, 95% CI:0.02-0.64, 451 patients) and a lower CO2 level [standard mean difference (MD) =-0.21, 95% CI:-0.4 to-0.03; 458 patients] in HFNO group compared to control group. Subgroup analysis focusing on risk of hypoxemia showed no significant subgroup effects, indicating consistent benefits of HFNO in different clinical settings. There were no difference in minimum SpO(2) (p = 0.06; 262 patients), risk of hypercapnia (p = 0.09; 393 patients), need for jaw thrust (p = 0.28; 2256 patients), and procedure time (p = 0.41, 1004 patients) between the two groups. Conclusion: Our results demonstrated the efficacy of high flow nasal oxygenation for reducing the risk of hyp-oxemia in patients receiving elective gastrointestinal endoscopic procedures under sedation. Further studies are warranted to verify its cost-effectiveness in the gastrointestinal endoscopy setting.
    關聯: Journal of Clinical Anesthesia, v.77, Article 110651
    Appears in Collections:[醫務管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat

    All items in CNU IR are protected by copyright, with all rights reserved.

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback